Document is current
Any future updates will be listed below
-
Authors
Miller, Brendan https://orcid.org/0000-0002-7461-7973
Vieira de Souza, Eduardo https://orcid.org/0000-0003-2773-8550
Lau, Calvin
Vaughan, Joan M.
Pai, Victor J.
Giraldez, Servando https://orcid.org/0000-0001-9543-9347
Rocha, Andréa
Diedrich, Jolene K. https://orcid.org/0000-0002-9044-980X
O’Shea, Clodagh C.
Bennett, David A.
Saghatelian, Alan https://orcid.org/0000-0002-0427-563X
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R01GM102491)
- License Information
-
More Information
Article History
Received: 3 October 2025
Accepted: 28 July 2026
First Online: 14 September 2026
Ethics
Competing interests: B.M., E.V.S. and A.S. have filed a patent related to ShortStop. A.S. is a shareholder and cofounder of Exo Therapeutics. The other authors declare no competing interests.
